Amendment# 1: Professional Scientific and Medical Guidance on NCI/CTEP Extramural Clinical Trials, Network Programs, and Treatment Trials

The National Cancer Institute requires professional scientific and medical guidance services from a subject matter expert to advise on its extramural clinical trials, network programs, and treatment trials managed by the Cancer Therapy Evaluation Program. The selected vendor must have an active medical license, ten years of oncology experience, and expertise in clinical trial design, regulation, and precision medicine initiatives to provide guidance on protocol development and amendments, respond to regulatory questions, and participate in monthly meetings. Quotes are due by July 2, 2021 and the contract will be awarded as a firm fixed price purchase order to the responsible vendor whose quote conforms to the solicitation and provides the best value based on technical qualifications and price.

There is no set-aside designation. The requirement is classified under NAICS code 541990 for specialty outpatient facilities with a business size standard of $16.5 million. The incumbent previously provided these services under Purchase Order Number HHSN261201700002B_75N91020F00012. The single-award purchase order will have a one base year term plus two option years and a place of performance in Bethesda, Maryland. Responses were provided to questions received by June 29, 2021 to clarify requirements under Solicitation Number 75N91021Q00070.